Korean Diabetes J.  2008 Oct;32(5):462-463. 10.4093/kdj.2008.32.5.462.

Relationship Between Serum Bilirubin Levels and Coronary Atherosclerosis in Patients with Type 2 Diabetes

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Korea.

Abstract

No abstract available.


MeSH Terms

Bilirubin
Coronary Artery Disease
Humans
Bilirubin

Reference

1. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs DR Jr. Gamma-glutamyltransferase and diabetes--a 4 year follow-up study. Diabetologia. 2003. 46:359–364.
2. Williams K, Haffner SM, Stern MP, Ferrannini E. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care. 2005. 28:1757–1762.
3. Nakanishi N, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2004. 27:1427–1432.
4. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care. 1998. 21:732–737.
5. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care. 2005. 28:2913–2918.
6. Cho NH, Jang HC, Choi SH, Kim HR, Lee HK, Chan JC, Lim S. Abnormal liver function test predicts type 2 diabetes: a community-based prospective study. Diabetes Care. 2007. 30:2566–2568.
7. Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K, Yamamoto Y, Yamashina A. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis. 2006. 189:198–205.
8. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994. 40:18–23.
9. Breimer LH, Spyropolous KA, Winder AF, Mikhailidis DP, Hamilton G. Is bilirubin protective against coronary artery disease? Clin Chem. 1994. 40:1987–1988.
10. Moon SJ, Chang WJ, Lee CH, Lee JE, Chun KA, Yoon JS, Cho IH, Lee HW, Won KC. Relationship Between Serum Bilirubin Levels and Coronary Atherosclerosis in Patients with Type 2 Diabetes. Korean Diabetes J. 2008. 32:338–345.
11. Djousse L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol. 2001. 87:1196–1200.
12. Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med. 2008. 121:781–788.
Full Text Links
  • KDJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr